CXCL9/mig mediates T cells recruitment to valvular tissue lesions of chronic rheumatic heart disease patients

Inflammation

Volumn 36, Issue 4, 2013, Pages 800-811

  Faé, Kellen C ^a,b   Palacios, Selma A ^a,b   Nogueira, Luciana G ^a,b   Oshiro, Sandra E ^a,b   Demarchi, Léa M F ^a   Bilate, Angelina M B ^a   Pomerantzeff, Pablo M A ^a   Brandão, Carlos ^a   Thomaz, Petronio G ^c,d   Dos Reis, Maxwell ^c,d   Sampaio, Roney ^a   Tanaka, Ana C ^a   Cunha Neto, Edecio ^a,b   Kalil, Jorge ^a,b   Guilherme, Luiza ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NATIONAL INSTITUTE OF SCIENCE AND TECHNOLOGY   (Brazil)

^c DEPEL   (Brazil)

^d Oncology Unit Marcio Cunha Hospital   (Brazil)

Author keywords

chemokines; CXCL9 (Mig); rheumatic fever; rheumatic heart disease; valvular lesions

Indexed keywords

CCL1 CHEMOKINE; CD4 ANTIGEN; CD45RO ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR3; CXCL9 CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA;

ADOLESCENT; ADULT; ARTICLE; CD4+ CD45RO+ T LYMPHOCYTE; CHILD; CHRONIC DISEASE; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; HEART MUSCLE; HEART MUSCLE BIOPSY; HEART VALVE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; IMMUNOREGULATION; LYMPHOCYTE MIGRATION; LYMPHOCYTIC INFILTRATION; MALE; MEMORY T LYMPHOCYTE; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRESCHOOL CHILD; PROTEIN EXPRESSION; RHEUMATIC HEART DISEASE; SCHOOL CHILD; UPREGULATION; VALVULAR HEART DISEASE;

ADOLESCENT; ADULT; CD4-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; CHEMOKINE CCL1; CHEMOKINE CCL3; CHEMOKINE CXCL9; CHILD; CHILD, PRESCHOOL; FEMALE; FIBROSIS; HEART VALVES; HUMANS; IMMUNOLOGIC MEMORY; MALE; MIDDLE AGED; MYOCARDIUM; NEOVASCULARIZATION, PATHOLOGIC; RHEUMATIC FEVER; RHEUMATIC HEART DISEASE; STREPTOCOCCUS PYOGENES; YOUNG ADULT;

STREPTOCOCCUS PYOGENES;

EID: 84880258310     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-013-9606-2     Document Type: Article

References (29)

1. Dajani, A.S.; E. Ayoub, F.Z. Bierman, A.L. Bisno, F.W. Denny, D.T. Durack, P. Ferrieri, M. Freed, M.D. Gerber, E. Kaplan, A.W. Karchmer, M. Markowitz, S.H. Rahimtoola, S.T. Shurman, G. Stollerman, M. Takahashi, A. Taranta, K.A. Taubert, W. Wilson, and D.T. Durack. 1992. Guidelines for the diagnosis of rheumatic fever. Jones criteria 1992 Update. Special writing group of the Committee on Rheumatic fever, Endocarditis and Kawasaki disease of the Council of Cardiovascular disease in the young of the American Heart Association. Journal of the American Medical Association 268: 2069-2073.
2. Lee, J.L.; S.M. Naguwa, G.S. Cheema, and M.E. Gershwin. 2009. Acute rheumatic fever and its consequences: a persistent threat to developing nations in the 21st century. Autoimmunity Reviews 9: 117-123.
3. Raizada, V.; R.C. Williams Jr.; P. Chopra, N. Gopinath, K. Prakash, K.B. Sharma, K.M. Cherian, S. Panday, R. Arora, M. Nigam, J.B. Zabriskie, and G. Husby. 1983. Tissue distribution of lymphocytes in rheumatic heart valves as defined by monoclonal anti-T cell antibodies. American Journal of Medicine 74: 90-96.
4. Marboe, C.C.; D.M. Knowles, M.B. Weiss, P.C. Ursell, and J. Fenoglio Jr. 1985. Monoclonal antibody identification of mononuclear cells in endomyocardial biopsy specimens from a patient with rheumatic carditis. Human Pathology 16: 332-338.
5. Kemeny, E.; T. Grieve, R. Marcus, P. Sareli, and J.B. Zabriskie. 1989. Identification of mononuclear cells and T cell subsets in rheumatic valvulitis. Clinical Immunology and Immunopathology 52: 225-237.
6. Guilherme, L.; E. Cunha-Neto, V. Coelho, R. Snitcowsky, P.M.A. Pommerantzeff, R.V. Assis, F.F. Pedra, J. Neumann, A.C. Goldberg, M.E. Patarroyo, F. Pillegi, and J. Kalil. 1995. Human heart-filtrating T cell clones from rheumatic heart disease patients recognize both streptococcal and cardiac proteins. Circulation 92: 415-420.
7. Amoils, B.; R.C. Morrison, A.A. Wadee, R. Marcus, D. Ninin, P. King, P. Sareli, S. Levin, and A.R. Rabson. 1986. Aberrant expression of HLA-DR antigen on valvular fibroblasts from patients with active rheumatic carditis. Clinical and Experimental Immunology 66: 88-94.
8. Narula, J.; P. Chopra, K.K. Talwar, K.S. Reddy, R.S. Vasan, R. Tandon, M.L. Bhatia, and J.F. Southern. 1993. Does endomyocardial biopsy aid in the diagnosis of active rheumatic carditis? Circulation 88: 2198-2205.
9. Gross, I.; and J.C. Ehrlich. 1934. Studies on the myocardial Aschoff body. American Journal of Pathology 10: 467-488.
10. Cunningham, M.W. 2000. Pathogenesis of group A streptococcal infections. Clinical Microbiology Reviews 13: 470-511.
11. Cunningham, M.W. 2008. Pathogenesis of group A streptococcal infections and their sequelae. Advances in Experimental Medicine and Biology 609: 29-42.
12. Roberts, S.; S. Kosanke, S. Terrence Dunn, D. Jankelow, C.M. Duran, and M.W. Cunningham. 2001. Pathogenic mechanisms in rheumatic carditis: focus on valvular endothelium. Journal of Infectious Diseases 183: 507-511.
13. Faé, K.C.; D.D. Silva, S.E. Oshiro, A.C. Tanaka, P.M. Pomerantzeff, C. Douay, D. Charron, A. Toubert, M.W. Cunningham, J. Kalil, and L. Guilherme. 2006. Mimicry in recognition of cardiac myosin peptides by heart-intralesional T cell clones from rheumatic heart disease. Journal of Immunology 176: 5662-5670.
14. Guilherme, L.; P. Cury, L.M. Demarchi, V. Coelho, L. Abel, A.P. Lopez, S.E. Oshiro, S. Aliotti, E.C. Neto, P.M. Pomerantzeff, A.C. Tanaka, and J. Kalil. 2004. Rheumatic heart disease: proinflammatory cytokines play a role in the progression and maintenance of valvular lesions. Americal Journal of Pathology 165: 1583-1591.
15. Livak, K.J.; and T.D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C (T)) method. Methods 25: 402-408.
16. Sallusto, F.; C.R. Mackay, and A. Lanzavecchia. 2000. The role of chemokine receptors in primary, effector, and memory immune responses. Annual Review of Immunology 18: 593-620.
17. Baggiolini, M.; B. Dewald, and B. Moser. 1994. Interleukin-8 and related chemotactic cytokines - CXC and CC chemokines. Advances in Immunology 55: 97-109.
18. Bonecchi, R.; G. Bianchi, P.P. Bordignon, D. D'Ambrosio, R. Lang, A. Borsatti, S. Sozzani, P. Allavena, P.A. Gray, A. Mantovani, and F. Sinigaglia. 1998. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. The Journal of Experimental Medicine 187: 129-134.
19. Zlotnik, A.; and O. Yoshie. 2000. Chemokines: a new classification system and their role in immunity. Immunity 12: 121-127.
20. Haque, N.S.; X. Zhang, D.L. French, J. Li, M. Poon, J.T. Fallon, B.R. Gabel, M.B. Taubman, M. Koschinsky, and P.C. Harpel. 2000. CC chemokine I-309 is the principal monocyte chemoattractant induced by apolipoprotein (a) in human vascular endothelial cells. Circulation 102: 786-792.
21. Miller, M.D.; S. Hata, R. De Waal Malefyt, and M.S. Krangel. 1989. A novel polypeptide secreted by activated human T lymphocytes. Journal of Immunology 143: 2907-2916.
22. Haque, N.S.; J.T. Fallon, M.B. Taubman, and P.C. Harpel. 2001. The chemokine receptor CCR8 mediates human endothelial cell chemotaxis induced by I-309 and Kaposi sarcoma herpesvirus-encoded vMIP-I and by lipoprotein (a)-stimulated endothelial cell conditioned medium. Blood 97: 39-45.
23. Bernardini, G.; G. Spinetti, D. Ribatti, G. Camarda, L. Morbidelli, M. Ziche, A. Santoni, M.C. Capogrossi, and M. Napolitano. 2000. I-309 binds to and activates endothelial cell functions and acts as an angiogenic molecule in vivo. Blood 96: 4039-4045.
24. Yoshioka, M.; S. Yuasa, K. Matsumura, K. Kimura, T. Shiomi, N. Kimura, C. Shukunami, Y. Okada, M. Mukai, H. Shin, R. Yozu, M. Sata, S. Ogawa, Y. Hiraki, and K. Fukuda. 2006. Chondromodulin-I maintains cardiac valvular function by preventing angiogenesis. Nature Medicine 12: 1151-1159.
25. Park, M.K.; D. Amichay, P. Love, E. Wick, F. Liao, A. Grinberg, R.L. Rabin, H.H. Zhang, S. Gebeyehu, and T.M. Wright. 2002. The CXC chemokine murine monokine induced by IFN-gamma (CXC chemokine ligand 9) is made by APCs, targets lymphocytes including activated B cells, and supports antibody responses to a bacterial pathogen in vivo. Journal of Immunology 169: 1433-1443.
26. Loetscher, M.; B. Gerber, P. Loetscher, S.A. Jones, L. Piali, I. Clark-Lewis, M. Baggiolini, and B. Moser. 1996. Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes. The Journal of Experimental Medicine 184: 963-969.
27. Guilherme, L.; N. Dulphy, C. Douay, V. Coelho, E. Cunha-Neto, S.E. Oshiro, R.V. Assis, A.C. Tanaka, P.M. Pomerantzeff, D. Charron, A. Toubert, and J. Kalil. 2000. Molecular evidence for antigen-driven immune responses in cardiac lesions of rheumatic heart disease patients. International Immunology 12: 1063-1074.
28. Akashi, S.; M. Sho, H. Kashizuka, K. Hamada, N. Ikeda, Y. Kuzumoto, Y. Tsurui, T. Nomi, T. Mizuno, H. Kanehiro, M. Hisanaga, S. Ko, and Y. Nakajima. 2005. A novel small-molecule compound targeting CCR5 and CXCR3 prevents acute and chronic allograft rejection. Transplantation 80: 378-384.
29. Schnickel, G.T.; S. Bastani, G.R. Hsieh, A. Shefizadeh, R. Bhatia, M.C. Fishbein, J. Belperio, and A. Ardehali. 2008. Combined CXCR3/CCR5 blockade attenuates acute and chronic rejection. Journal of Immunology 180: 4714-4721. Tecnológico